On a high: the continued advance of equities means one influential strategist sees almost no value in the US market and precious little elsewhere.Photograph: Brendan McDermid/Reuters

The US stock market is “hideously expensive,” according to James Montier, an influential strategist with GMO, a global investment management firm bas(...)

Approximately 100 new jobs have been announced in Limerick by a division of medtech giant Johnson & Johnson. Information Technology Shared Service(...)

An Ebola patient arriving at Geneva University Hospital HUG in Geneva, Switzerland on November 21st. Early safety trials for a new vaccine to combat the deadly disease have had encouraging results. Photograph: EPA/Julien Gregorio

An experimental Ebola vaccine caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-(...)

J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of Tuesday had a market capitalisation of $17.8 billion

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback (...)

Virgin America president David Cush in the New York Stock Exchange yesterday before the company’s shares’ first day of trading. Photograph: Michael Loccisano/Getty Images

European stocks were little changed as slides in healthcare and commodity stocks offset gains in media companies.Eurostat, the EU’s official number c(...)

World Health Organisation assistant director general Marie Paule Kieny at a news conference on Ebola vaccines in Geneva yesterday.Photograph: Denis Balibouse/Reuters

The World Health Organisation (WHO) set out plans yesterday for speeding up development and deployment of experimental Ebola vaccines, saying hundred(...)

A medic holds a package of an experimental candidate vaccine rVSV-ZEBOV against Ebola virus disease at the University hospital in Geneva. Photograph: Mathilde Missioneiro/Reuters/WHO

Trials of Ebola vaccines could begin in West Africa in December, a month earlier than expected, and hundreds of thousands of doses should be availabl(...)

Planet Business

Image of the week: Good impressionists Edouard Manet’s Le Printemps is pictured on display at Christie’s Auction House in Paris, where it is about to (...)

Nice moves in the airlines, with Aer Lingus and Ryanair both climbing.Photograph: Niall Carson/PA Wire

A rebound on Wall Street buoyed global equity markets yesterday, but lingering anxiety over world economic growth pushed US and German bond prices hi(...)

J&J said it now expects full-year earnings, excluding special items, of $5.92 to $5.97 per share

Johnson & Johnson reported better than expected quarterly earnings, boosted by surging sales of a new drug for hepatitis C that are expected to e(...)